N'-NITROSOANATABINE

O=NN1CC=CC[C@H]1C2=CN=CC=C2

InChIKey=ZJOFAFWTOKDIFH-JTQLQIEISA-N

InChI=1S/C10H11N3O/c14-12-13-7-2-1-5-10(13)9-4-3-6-11-8-9/h1-4,6,8,10H,5,7H2/t10-/m0/s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

PubMed

Title	Date	PubMed
Glucuronidation of tobacco-specific nitrosamines by UGT2B10.	2008-05	18238858
Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP.	2002-08	12214673
Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase.	2001	11774366

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 20:02:33 GMT 2025` Edited by `admin` on `Mon Mar 31 20:02:33 GMT 2025`
Record UNII	7V3JJ391AU
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

N'-NITROSOANATABINE

Common Name

English

N-NITROSOANATABINE

Preferred Name

English

N'-NITROSOANATABINE [IARC]

Common Name

English

2,3'-BIPYRIDINE, 1,2,3,6-TETRAHYDRO-1-NITROSO-, (S)-

Systematic Name

English

NAT

Common Name

English

2,3'-BIPYRIDINE, 1,2,3,6-TETRAHYDRO-1-NITROSO-, (2S)-

Systematic Name

English

Code System Code Type Description

FDA UNII

7V3JJ391AU